SAGE PRO

Home / Research / Exide Industries Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Exide Industries Limited — Q2 FY27 Results Analysis

Standalone revenue grew 20.3%

Published · Quarter Q2 FY27 · EXIDEIND

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Q2 standalone revenue

Q2 FY26₹4,178 crore
Q2 FY27₹5,026 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 2

Q2 standalone EBITDA

Q2 FY26₹395 crore
Q2 FY27₹606 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 3

Q2 EBITDA margin

Q2 FY269.4%
Q2 FY2712.1%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 4

Q2 PBT

Q2 FY26₹298 crore
Q2 FY27₹522 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Standalone revenue grew 20.3%

Q2 standalone revenue was 4178 ₹ crore (Q2 FY26) versus 5026 ₹ crore (Q2 FY27). Standalone revenue grew 20.3%.

Watch: Separate new energy business

RESEARCH INSIGHT

EBITDA improved 53.6%

Q2 standalone EBITDA was 395 ₹ crore (Q2 FY26) versus 606 ₹ crore (Q2 FY27). EBITDA improved 53.6%.

Watch: Monitor cost of lead

RESEARCH INSIGHT

Standalone EBITDA margin expanded 270 bps

Q2 EBITDA margin was 9.4 % (Q2 FY26) versus 12.1 % (Q2 FY27). Standalone EBITDA margin expanded 270 bps.

Watch: Check recurring gross margin

RESEARCH INSIGHT

Profit before tax grew sharply

Q2 PBT was 298 ₹ crore (Q2 FY26) versus 522 ₹ crore (Q2 FY27). Profit before tax grew sharply.

Watch: Reconcile depreciation

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Quarter ended September 2026 · Stance WATCH · issuer-sourced consolidated/standalone bases noted. Exide's core battery operation reported a stronger standalone Q2: revenue ₹5,026 crore compared with ₹4,178 crore, EBITDA ₹606 crore versus ₹395 crore, and PAT ₹386 crore versus ₹221 crore. The key portfolio question is whether lead-acid cash generation can fund a credible transition into lithium-ion cells without assuming the gigafactory has already earned mature returns. Standalone profitability is not consolidated new-energy project profitability. WATCH until cash requirements, customer qualification and ramp-up returns become clearer. [S1][S2]

Key decision figurePrior periodCurrent period
Q2 standalone revenue4178 ₹ crore (Q2 FY26)5026 ₹ crore (Q2 FY27)
Q2 standalone EBITDA395 ₹ crore (Q2 FY26)606 ₹ crore (Q2 FY27)
Q2 EBITDA margin9.4 % (Q2 FY26)12.1 % (Q2 FY27)
Q2 PBT298 ₹ crore (Q2 FY26)522 ₹ crore (Q2 FY27)
Q2 PAT221 ₹ crore (Q2 FY26)386 ₹ crore (Q2 FY27)
H1 revenue8688 ₹ crore (H1 FY26)10331 ₹ crore (H1 FY27)
H1 EBITDA943 ₹ crore (H1 FY26)1262 ₹ crore (H1 FY27)
H1 PBT727 ₹ crore (H1 FY26)1066 ₹ crore (H1 FY27)

Six data-driven investor takeaways: Q2 standalone revenue: Standalone revenue grew 20.3%. Q2 standalone EBITDA: EBITDA improved 53.6%. Q2 EBITDA margin: Standalone EBITDA margin expanded 270 bps. Q2 PBT: Profit before tax grew sharply. Q2 PAT: PAT rose around 75%. H1 revenue: Six-month sales grew 18.9%. This original research text sits under the separate, sourced graphical Investment Briefing, and the source identifiers remain privately encoded in the report's provenance record.

Chapter 1 — Investor decision and valuation requirements

Exide's core battery operation reported a stronger standalone Q2: revenue ₹5,026 crore compared with ₹4,178 crore, EBITDA ₹606 crore versus ₹395 crore, and PAT ₹386 crore versus ₹221 crore. The key portfolio question is whether lead-acid cash generation can fund a credible transition into lithium-ion cells without assuming the gigafactory has already earned mature returns. Standalone profitability is not consolidated new-energy project profitability. WATCH until cash requirements, customer qualification and ramp-up returns become clearer. [S1][S2]

Factual tests for the investment case

  • Q2 standalone revenue: 5026 ₹ crore (Q2 FY27) versus 4178 ₹ crore (Q2 FY26). Standalone revenue grew 20.3%; Separate new energy business. [S2]
  • Q2 standalone EBITDA: 606 ₹ crore (Q2 FY27) versus 395 ₹ crore (Q2 FY26). EBITDA improved 53.6%; Monitor cost of lead. [S2]
  • Q2 EBITDA margin: 12.1 % (Q2 FY27) versus 9.4 % (Q2 FY26). Standalone EBITDA margin expanded 270 bps; Check recurring gross margin. [S2]

What this means for the next reporting period. Standalone revenue grew 20.3%. A substantive follow-up is to separate new energy business. EBITDA improved 53.6%. A substantive follow-up is to monitor cost of lead. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 2 — Reported Q2 and H1 and quality of earnings

The presentation's standalone results show Q2 revenue growing 20.3% YoY and EBITDA 53.6%, expanding EBITDA margin from 9.4% to 12.1%. PBT advanced from ₹298 crore to ₹522 crore, while standalone PAT grew from ₹221 crore to ₹386 crore. H1 sales reached ₹10,331 crore from ₹8,688 crore, H1 EBITDA increased from ₹943 crore to ₹1,262 crore and H1 PAT from ₹541 crore to ₹794 crore. These are the existing battery company's reported standalone measures; they do not necessarily include full economics of future lithium cell production. [S1][S2]

Factual tests for the investment case

  • Q2 EBITDA margin: 12.1 % (Q2 FY27) versus 9.4 % (Q2 FY26). Standalone EBITDA margin expanded 270 bps; Check recurring gross margin. [S2]
  • Q2 PBT: 522 ₹ crore (Q2 FY27) versus 298 ₹ crore (Q2 FY26). Profit before tax grew sharply; Reconcile depreciation. [S2]
  • Q2 PAT: 386 ₹ crore (Q2 FY27) versus 221 ₹ crore (Q2 FY26). PAT rose around 75%; Observe tax and cash. [S2]

What this means for the next reporting period. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Profit before tax grew sharply. A substantive follow-up is to reconcile depreciation. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 3 — Products, therapeutic / operating segments and channels

Exide's installed brand and distribution network spans automotive OEM and replacement applications, telecom, industrial power, motive power and backup batteries. The company cited 120,000-plus customer touchpoints and more than 75 automotive OEM relationships, with major vertical integration into lead recycling. That channel depth helps price, warranty and repeat demand economics but can also expose working capital to lead prices and replacement cycles. Product localization and warranty claims are critical for assessing genuine margin quality. [S1][S2]

Factual tests for the investment case

  • Q2 PAT: 386 ₹ crore (Q2 FY27) versus 221 ₹ crore (Q2 FY26). PAT rose around 75%; Observe tax and cash. [S2]
  • H1 revenue: 10331 ₹ crore (H1 FY27) versus 8688 ₹ crore (H1 FY26). Six-month sales grew 18.9%; Assess mix and volumes. [S2]
  • H1 EBITDA: 1262 ₹ crore (H1 FY27) versus 943 ₹ crore (H1 FY26). H1 EBITDA increased 33.8%; Test cost sustainability. [S2]

What this means for the next reporting period. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Six-month sales grew 18.9%. A substantive follow-up is to assess mix and volumes. H1 EBITDA increased 33.8%. A substantive follow-up is to test cost sustainability. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 4 — Management execution and analyst Q&A challenges

The company described the commissioning of its Exide Energy Solutions 6 GWh lithium-ion cell gigafactory in September 2026, alongside lithium packs/modules and cell-chemistry capabilities. Commissioning is a technical and commercial milestone, not proof of targeted production yield, full utilization or immediate cash recovery. Management highlighted OEM business in electric and conventional vehicles and new product launches; contracted customer qualification, offtake, manufacturing scrap and cell pricing should be monitored before adding new-energy profits into a base-case model. [S1][S2]

Factual tests for the investment case

  • H1 EBITDA: 1262 ₹ crore (H1 FY27) versus 943 ₹ crore (H1 FY26). H1 EBITDA increased 33.8%; Test cost sustainability. [S2]
  • H1 PBT: 1066 ₹ crore (H1 FY27) versus 727 ₹ crore (H1 FY26). Half-year PBT grew ~46%; Reconcile capex. [S2]
  • H1 PAT: 794 ₹ crore (H1 FY27) versus 541 ₹ crore (H1 FY26). H1 PAT grew ~47%; Review dividend funding. [S2]

What this means for the next reporting period. H1 EBITDA increased 33.8%. A substantive follow-up is to test cost sustainability. Half-year PBT grew ~46%. A substantive follow-up is to reconcile capex. H1 PAT grew ~47%. A substantive follow-up is to review dividend funding. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 5 — Cash generation, capex, debt and asset payback

Exide's snapshot describes a zero-debt balance sheet and long-running cash generation in its mature businesses, but the gigafactory investment changes expected capital intensity and financing needs. Cell manufacturing carries depreciation, equipment obsolescence, raw-material sourcing and qualification costs; the timing of internal cash transfers to the subsidiary matters.

Q2 standalone EBITDA ₹606 crore cannot be treated as free cash available for dividends or new plants without the actual consolidated cash-flow statement and approved capex commitments. The presentation's zero-debt description should be read as presented, not extrapolated to all future reporting periods. [S1][S2]

Factual tests for the investment case

  • H1 PAT: 794 ₹ crore (H1 FY27) versus 541 ₹ crore (H1 FY26). H1 PAT grew ~47%; Review dividend funding. [S2]
  • H1 EBITDA margin: 12.2 % (H1 FY27) versus 10.9 % (H1 FY26). H1 margin improved 130 bps; Test replacement demand. [S2]
  • Q2 PBT margin: 10.4 % (Q2 FY27) versus 7.1 % (Q2 FY26). PBT margin increased 330 bps; Separate finance effects. [S2]

What this means for the next reporting period. H1 PAT grew ~47%. A substantive follow-up is to review dividend funding. H1 margin improved 130 bps. A substantive follow-up is to test replacement demand. PBT margin increased 330 bps. A substantive follow-up is to separate finance effects. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 6 — Conditional bull/base/bear scenarios and falsifiers

An upside case involves battery demand growth across auto, replacement and industrial sectors, stable pricing/lead costs and qualified customer uptake from the cell facility at acceptable yields. Base conditions have good standalone cash earnings while lithium commercialization produces delayed returns and upfront depreciation. Downside risks include lead-price inflation, warranty failures, cell oversupply, technology change or substantially lower gigafactory utilization. Future capacity should be assessed as a risk-bearing investment, not current earnings automatically capitalized. [S1][S2]

Factual tests for the investment case

  • Q2 standalone revenue: 5026 ₹ crore (Q2 FY27) versus 4178 ₹ crore (Q2 FY26). Standalone revenue grew 20.3%; Separate new energy business. [S2]
  • Q2 standalone EBITDA: 606 ₹ crore (Q2 FY27) versus 395 ₹ crore (Q2 FY26). EBITDA improved 53.6%; Monitor cost of lead. [S2]
  • Q2 EBITDA margin: 12.1 % (Q2 FY27) versus 9.4 % (Q2 FY26). Standalone EBITDA margin expanded 270 bps; Check recurring gross margin. [S2]

What this means for the next reporting period. Standalone revenue grew 20.3%. A substantive follow-up is to separate new energy business. EBITDA improved 53.6%. A substantive follow-up is to monitor cost of lead. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Chapter 7 — Quarterly investor action plan and monitoring

WATCH standalone quarterly revenue ₹5,026 crore, EBITDA ₹606 crore and PAT ₹386 crore, with Q2 FY26 comparisons; monitor H1 revenue ₹10,331 crore and EBITDA ₹1,262 crore. Separately track cell plant utilization against the 6 GWh announced capacity, OEM qualifications, recycling economics and net capital support to the new-energy business. Upgrade only when incremental plant returns and cash conversion support current price; downgrade if capex requirements overwhelm legacy profits or cell pricing weakens. [S1][S2]

Factual tests for the investment case

  • Q2 EBITDA margin: 12.1 % (Q2 FY27) versus 9.4 % (Q2 FY26). Standalone EBITDA margin expanded 270 bps; Check recurring gross margin. [S2]
  • Q2 PBT: 522 ₹ crore (Q2 FY27) versus 298 ₹ crore (Q2 FY26). Profit before tax grew sharply; Reconcile depreciation. [S2]
  • Q2 PAT: 386 ₹ crore (Q2 FY27) versus 221 ₹ crore (Q2 FY26). PAT rose around 75%; Observe tax and cash. [S2]

What this means for the next reporting period. Standalone EBITDA margin expanded 270 bps. A substantive follow-up is to check recurring gross margin. Profit before tax grew sharply. A substantive follow-up is to reconcile depreciation. PAT rose around 75%. A substantive follow-up is to observe tax and cash. Management goals, future launches, announced capacity and unearned cash inflows are not booked as realized revenue or profit. The periods, currencies, reported and adjusted accounting labels must be held constant when recomputing growth.

Clickable issuer and exchange filings

[S1] Exide Industries Limited Q2 FY27 earnings-call transcript — accepted transcript covering management and investor questions about the September quarter. [S2] Exide Industries Limited Q2 and H1 FY27 investor presentation — financial statements and management operating metrics.

Evidence limitations: Company filings are the research source. Specific valuation multiples, market price, future dividends, share counts or debt forecasts are omitted when not supported by these documents. Management guidance and the issuer's adjusted figures must not be mistaken for statutory earnings, or for independently certified cash flow.

Additional company evidence

CHART 5

Q2 PAT

Q2 FY26₹221 crore
Q2 FY27₹386 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 6

H1 revenue

H1 FY26₹8,688 crore
H1 FY27₹10,331 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 7

H1 EBITDA

H1 FY26₹943 crore
H1 FY27₹1,262 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

CHART 8

H1 PBT

H1 FY26₹727 crore
H1 FY27₹1,066 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660daf15-6e1a-4ccd-8ee9-b4fef9285260.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.